CH555832A - Procede pour la preparation de nouvelles pyrimidinones. - Google Patents

Procede pour la preparation de nouvelles pyrimidinones.

Info

Publication number
CH555832A
CH555832A CH1507872A CH1507872A CH555832A CH 555832 A CH555832 A CH 555832A CH 1507872 A CH1507872 A CH 1507872A CH 1507872 A CH1507872 A CH 1507872A CH 555832 A CH555832 A CH 555832A
Authority
CH
Switzerland
Prior art keywords
pyrimidinones
preparation
new
new pyrimidinones
Prior art date
Application number
CH1507872A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CH555832A publication Critical patent/CH555832A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CH1507872A 1971-10-29 1972-10-16 Procede pour la preparation de nouvelles pyrimidinones. CH555832A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (1)

Publication Number Publication Date
CH555832A true CH555832A (fr) 1974-11-15

Family

ID=22715935

Family Applications (2)

Application Number Title Priority Date Filing Date
CH165674A CH549579A (fr) 1971-10-29 1972-10-16 Procede pour la preparation de nouvelles hydroxy-pyrimidines.
CH1507872A CH555832A (fr) 1971-10-29 1972-10-16 Procede pour la preparation de nouvelles pyrimidinones.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH165674A CH549579A (fr) 1971-10-29 1972-10-16 Procede pour la preparation de nouvelles hydroxy-pyrimidines.

Country Status (25)

Country Link
JP (2) JPS5337870B2 (fr)
AR (2) AR198798A1 (fr)
AT (2) AT320656B (fr)
AU (1) AU467600B2 (fr)
BE (1) BE790125A (fr)
CA (1) CA980778A (fr)
CH (2) CH549579A (fr)
DE (3) DE2264657C2 (fr)
DK (1) DK131465B (fr)
EG (1) EG11013A (fr)
ES (2) ES407730A1 (fr)
FI (1) FI55503C (fr)
FR (1) FR2157865B1 (fr)
GB (2) GB1377308A (fr)
IE (1) IE37043B1 (fr)
IL (2) IL40458A (fr)
LU (1) LU66304A1 (fr)
NL (1) NL166470C (fr)
NO (1) NO136574C (fr)
PH (2) PH10129A (fr)
PL (2) PL84634B1 (fr)
SE (2) SE393376B (fr)
SU (2) SU498908A3 (fr)
YU (2) YU35125B (fr)
ZA (1) ZA727362B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (fr) * 1979-04-17 1980-11-01
JPS5752409Y2 (fr) * 1979-11-05 1982-11-15
DE3222914A1 (de) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JPH0655686B2 (ja) * 1988-08-30 1994-07-27 宇部興産株式会社 ｐ−ブロモフェノキシアセトアルデヒドジアルキルアセタール類の製造方法
US7776870B2 (en) 2005-08-22 2010-08-17 Melior Pharmaceuticals I, Inc. Methods for modulating Lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (fr) 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prévention de la dégénérescence des cellules pancréatiques bêta
BR112019021140A2 (pt) 2017-04-10 2020-05-19 Univ Louisiana State composição, método para reduzir os níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento, método de indução do bege de adipócitos ou prevenção da degeneração das células beta do pâncreas, e, ativador de lyn cinase e agonista de trpm8 para uso na redução dos níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951431A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
IL48790A0 (en) 1976-03-31
AR198798A1 (es) 1974-07-24
NL7213959A (fr) 1973-05-02
PH11594A (en) 1978-03-31
ES407730A1 (es) 1976-01-16
YU36295B (en) 1982-06-18
JPS4852780A (fr) 1973-07-24
SE397090B (sv) 1977-10-17
FI55503B (fi) 1979-04-30
YU99179A (en) 1981-08-31
FI55503C (fi) 1979-08-10
AR196263A1 (es) 1973-12-10
FR2157865A1 (fr) 1973-06-08
CH549579A (fr) 1974-05-31
DK131465B (da) 1975-07-21
IE37043L (en) 1973-04-29
DE2264374A1 (de) 1973-05-24
SE393376B (sv) 1977-05-09
JPS5337870B2 (fr) 1978-10-12
NO136574C (no) 1977-09-28
YU35125B (en) 1980-09-25
ZA727362B (en) 1973-11-28
AT321308B (de) 1975-03-25
FR2157865B1 (fr) 1975-10-31
AU4722872A (en) 1974-04-04
BE790125A (fr) 1973-04-16
PH10129A (en) 1976-09-02
JPS5422995B2 (fr) 1979-08-10
YU255172A (en) 1980-03-15
DK131465C (fr) 1975-12-08
SE7505279L (sv) 1975-05-06
EG11013A (en) 1976-11-30
NL166470B (nl) 1981-03-16
SU498908A3 (ru) 1976-01-05
IE37043B1 (en) 1977-04-27
JPS53116386A (en) 1978-10-11
DE2248741A1 (de) 1973-05-03
DE2248741C3 (de) 1975-06-26
ES436624A1 (es) 1977-02-01
LU66304A1 (fr) 1973-05-03
DE2264374C3 (de) 1981-07-23
AT320656B (de) 1975-02-25
IL40458A (en) 1976-05-31
DE2264657A1 (de) 1974-06-20
NL166470C (nl) 1981-08-17
CA980778A (en) 1975-12-30
NO136574B (fr) 1977-06-20
GB1377308A (en) 1974-12-11
DE2264657C2 (de) 1982-09-16
GB1377720A (en) 1974-12-18
IL40458A0 (en) 1972-11-28
IL48790A (en) 1976-05-31
DE2248741B2 (de) 1974-11-14
DE2264374B2 (de) 1980-08-07
PL89852B1 (fr) 1976-12-31
PL84634B1 (fr) 1976-04-30
SU505362A3 (ru) 1976-02-28
AU467600B2 (en) 1975-12-04

Similar Documents

Publication Publication Date Title
RO62435A (fr) Procede pour la preparation des 1,2,4-triazolenucleosides
CH553856A (fr) Procede pour la fabrication de fibrilles discontinues.
RO67478A (fr) Procede pour la preparation des pleuromutillines
RO62762A (fr) Procede pour la preparation des(1,5a)-pyrimidines 3,5,7-tri-substitues
RO62694A (fr) Procede pour la preparation des 3-methylencephalosporines
CH555832A (fr) Procede pour la preparation de nouvelles pyrimidinones.
BE790181A (fr) Procede pour la preparation de trichloromethansulfenylchlorure
CH550151A (fr) Procede de preparation de nouvelles iodomethylsulfones.
CH553178A (fr) Procede pour la preparation de la 3-hydroxy-2-alcoyl4-pyrone.
CH554334A (fr) Procede pour la preparation de tetrahydrocarbazole.
BE790056A (fr) Procede de preparation de 1, 1'-dianthraquinonyles
CH553216A (fr) Procede de preparation de ceteniminepenicillines.
CH552620A (fr) Procede de preparation de nouvelles quinoleines substittuees.
RO67345A (fr) Procede pour la preparation du6-aza-1,2-dihydro-3h-1,4-benzodyazepines
RO64143A (fr) Procede pour la preparation des 5-alkyle-5 aralcolxy-1,3-dioxanes
CH556330A (fr) Procede de preparation de cyclohexadienylamidoalcoylphenylsulfonylurees.
RO62774A (fr) Procede pour la preparation des ryphamicynes s.v
BE790055A (fr) Procede de preparation de 1,1'-dianthraquinonyles
BE786966R (fr) Procede pour la preparation de
BE779539A (fr) Procede pour la preparation de butanone-alpha-mono-cyano-ethylee
CH556339A (fr) Procede pour la preparation de 2,6-methano-3-benzazocines.
BE761159A (fr) Procede pour la preparation de 2,2-dialcoyl-3-acyloxy -propanals
BE761876A (fr) Procede pour la preparation de 1, 1' - peroxydicyclohexylamine
BE805859R (fr) Procede pour le dedoublement racenique de d,1-phenylpropanolamine
BE799233A (fr) Procede pour la preparation de methylbutenol,

Legal Events

Date Code Title Description
PL Patent ceased